ABOUT ISSED

The International Society for the Study of Emerging Drugs (ISSED) is established to unite the world’s multidisciplinary leaders on Novel Psychoactive Substances (NPS), emerging substances, and associated trends in regularized discourse, partnership and study, with a goal to develop innovative strategies for interventions, while counteracting the threat posed by NPS and emergent substances in society.

Through collaboration of international leaders working in the fields of medicine, public health, law enforcement, forensic sciences, drug policy, social sciences, and academia, commonalities in emergent trends and substances will be expediently identified, studied, and integrated into informed public health and public safety policy.

AIMS

To provide a platform for a multidisciplinary collaboration on NPS and other emergent substances

To promote interdisciplinary study and research on NPS through collaborative publishing as well as rapid sharing of information on NPS identifications, usage trends, trafficking trends, change in policy and best practices on public health interventions, education and prevention activities

To promote interdisciplinary education and training programs on NPS and emergent substances

BOARD MEMBERS

  • President – Ornella Corazza (University of Hertfordshire)
  • Vice President – Barry Logan (The Center for Forensic Science Research & Education)
  • Roumen Sedefov (The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
  • Ana Gallegos (The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
  • Justice Tettey (United Nations Office on Drugs and Crime)
  • Sabrina Levissianos (United Nations Office on Drugs and Crime)
  • Olivier Rabin (World Anti-Doping Agency)
  • Irene Mazzoni (World Anti-Doping Agency)
  • Fabrizio Schifano (University of Hertfordshire)
  • Owen Bowden Jones (University College London)
  • Andres Roman-Urrestarazu (University of Cambridge)
  • Giovanni Martinotti (University of Chieti-Pescara)
  • Johannes Ramaekers (Maastricht University)
  • Matthew Young (Canadian Centre on Substance Use and Addiction)
  • Noam Fast (Department of Defense, US Air Force)
  • Balasingam Vicknasingam (Universiti Sains Malaysia)
  • Giuseppe Bersani (Sapienza University)
  • Raimondo Bruno (University of Tasmania)
  • M.J. Menendez (NMS Labs)
  • Ruri Kikura-Hanajiri (National Institute of Health Sciences)
  • Francesco Botre’ (University of Lausanne)
  • Antonio Metastasio (Camden and Islington NHS Trust)
  • Mariya Prilutskaya (Semey Medical University)

JOIN ISSED

By joining ISSED, you will gain:

  • Access to private membership area with ISSED blog and information exchange NEW
  • Networking with ISSED Members
  • Discounted access to the International Conference Series on Novel Psychoactive Substances
  • Complementary access to the Online Archive with over 300 presentations on Novel Psychoactive Substances
  • Periodic Newsletter with latest news, opportunities for collaboration and events
  • 50% discount on open access charge for publications in the Journal of Emerging Trends in Drugs, Addictions and Health

Annual Regular rate: $140

Annual Student rate: $100

(A valid student ID will need to be provided, please e-mail a scan/photo of your student ID to info@issed.net within 24 hours)

International Society for the Study of Emerging Drugs

(optional)

Or enter your payment details below

Novel Psychoactive Substances: Policy, Economics and Drug Regulation

In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon, offering a guide to inform legislative discussions and demonstrating from a comparative perspective the different approaches used to address the rise of NPS to date. It covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory approaches also in less explored settings such as prisons and sport environments.

Available on Amazon

Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS

Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the serious public health concern that NPS pose. It presents various clinical cases, as well as detailed accounts of symptoms, psychopathology, toxicity, and overall clinical management that NPS require. This handbook brings together a unique collection of chapters written by leading experts in the field, who have felt the need to share their knowledge and experience to improve the clinical practice on NPS and the wellbeing of their patients.

Available on Amazon

Club Drugs and Novel Psychoactive Substances: The Clinician’s Handbook (Royal College of Psychiatrists)

by Owen Bowden-Jones (Author), Dima Abdulrahim (Author)

Over the last decade many hundreds of new psychoactive drugs have emerged onto illicit markets. This flood of new drugs has led to clinicians being unsure of the rapidly emerging changing evidence base and uncertain of the best approaches to assessment and clinical management. This book provides a concise, accessible summary of these emerging drugs. By categorizing the hundreds of new drugs by their predominant psychoactive effect – sedative, stimulant and hallucinogenic – the book helps clinicians to manage a drug they are unfamiliar with by using their experience of other drugs with similar psychoactive properties. Written for clinicians from across the frontline, from A&E staff to drug treatment professionals, the authors draw on numerous clinical examples from their own clinical experiences to illustrate aspects of assessment and management. Club drugs and novel psychoactive substances will continue to challenge clinicians and this handbook provides readers with an invaluable introduction to this complex area.

Available on Amazon

The Drug Conversation: How to Talk to Your Child About Drugs Kindle Edition

by Owen Bowden-Jones

The Drug Conversation is a guide for parents about how to raise the thorny issue of drugs with their children. It will help you begin a useful conversation about drugs with your child.

This book provides information on the different types of drugs available, their attractions and harms, how they work in the brain, and who uses them and why. It covers issues such as how to detect drug use, drug testing, synthetic drugs (‘legal highs’), accessing help, effective treatments and what to expect from professional medical services.

All parents will need this book at some stage. It will help you to feel properly informed about drugs, more confident in talking to your child, more able to keep drug-related problems from developing and better equipped to tackle problems if they do arise.

Available on Amazon